S 8991 New York Senate · 2023 Regular Session

Relates to the availability of opioid reversal agents

Summary
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2024
Committee Review
Floor Vote
Governor
Introduced Apr 8, 2024 Last action Jun 3, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
2
Committee
1
Amendments
2
Jun 3, 2024
Upper · Passed
PRINT NUMBER 8991A
upper
Jun 3, 2024
Upper · Passed
AMEND AND RECOMMIT TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
upper
Apr 8, 2024
Committee
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
upper
1 primary · 5 co-sponsors

Sponsors